We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.
ARTICLE · 07 APRIL 2010
En Banc Federal Circuit Confirms Section 112, Paragraph 1 Includes a Separate Written Description Requirement
McDermott Will & Emery
In a 9–2 en banc decision, a majority of the U.S. Court of Appeals for the Federal Circuit reaffirmed that the U.S. Patent Laws (35 U.S.C. § 112, ¶1) impose a written description requirement separate and apart from the enablement requirement. Ariad Pharmaceuticals, Inc. v. Ely Lilly & Co.
United StatesIntellectual Property










